On a corporate action affecting ordinary shares of Nevro Corp. (NVRO)

On February 6, 2025, Nevro Corp. entered into a merger agreement under which it will be acquired by Globus Medical, Inc. Nevro Corp. stockholders will receive $5.85 in cash for each share of Nevro Corp. that they own if transaction is approved by stockholders on the special meeting of stockholders to be held on April 2, 2025. Transaction is expected to close late in the second quarter of 2025. For more details, please, refer to the company’s website.

ITS Ltd. will publish separate notices on the procedures undertaken by ITS Ltd. to process this corporate action outlining how trading in these qualified investments will be carried out.